Introduction. Stenting and bypass surgery is widely introduced into clinical practice of the Republic of Kazakhstan. However, issues of quality of life, health status remain very debatable in scientific circles.

Aim: to analyze the literature devoted to the study of the quality of life and objective state of health of patients before or after surgical treatment of ischemic heart disease, as well as indicators of QALY patients after surgical treatment of ischemic heart disease.

Search strategy: literature search was carried out by manual method using key words (coronary heart disease, stenting, coronary artery bypass grafting, survival, quality of life, QALY), as well as literature sources of evidence databases "PubMed" and "Web of science" were considered, with the help of specialized search engines (Google Scholar) and electronic scientific libraries (CyberLeninka, e-library). The depth of the study is 10 years (from 2008 to 2018). Inclusion criteria: high methodological quality studies: meta-analysis, systematic review and cohort studies, as well as publications with well-formulated and statistically proven findings. Exclusion criteria: abstracts, personal messages, promotional articles. Only those literary sources that reflected the problem from the standpoint of survival and quality of life of patients operated by these methods of treatment and financial costs of surgery were subject to study.

Results: a review of literature has shown that drug-coated stenting (regardless of the type of drug) is more clinically effective than other types of stenting; the quality of life associated with health goes beyond physical symptoms, with activity limitations, social support and participation, and personal perceptions.

Conclusions: further research is needed to identify the dynamics and relationships between these areas, including longitudinal trends in health-related quality of life indicators; coronary artery bypass grafting has a higher cost-effectiveness than stenting in the long term at a higher cost of the former.

Madina B. Kokenova 1, http://orcid.org/0000-0002-4219-5737

Ayan O. Myssayev 1, http://orcid.org/0000-0001-7332-4856

Zukhra S. Siyazbekova 1, http://orcid.org/0000-0001-9244-7085


Semey State Medical University, Semey, Republic of Kazakhstan

1. Гринштейн Ю.И., Кусаев В.В., Губич С.Г. Качество жизни больных, перенесших острый инфаркт миокарда с различными видами реваскуляризации // Кардиология. 2012. Т. 5. С 92–95.

2. Burden of disease: DALYs World Health Organization. Available at: http://www.who.int/quantifying_ehimpacts/publications/en/9241546204chap3.pdf (accessed 30.10.2018).

3. Cohen D.J., Van Hout B, Serruys P.W, Mohr F.W, Macaya C, den Heijer P, Vrakking M.M, Wang K, Mahoney E.M, Audi S, Leadley K, Dawkins K.D. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery // 2012. Т. 56. № 1. 2012. Available at: https://www.nejm.org/doi/10.1056/NEJMoa1001508?url_ver=Z39.882003&rfr_id=ori%3Arid%3Acrossre... (accessed 22.10.2018).

4. Ferko N. et al. Cost-Effectiveness of Percutaneous Coronary Intervention with Cobalt-Chromium Everolimus Eluting Stents versus Bare Metal Stents : Results from a Patient Level meta-Analysis of Randomized Trials // 2017. Т. 1002. №2 June 2016. p 994–1002.

5. Giuseppe De Luca, Maurits T. Dirksen, Henning Kelbæk, Leif Thuesen, Marteen A. Vink, Christoph Kaiser, Tania Chechi, Gaia Spaziani, Emilio Di Lorenzo, Harry Suryapranata G.W.S. Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials // Springer Sci. Media. 2014. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609523/pdf/1020.pdf (accessed 10.11.2018).

6. Head S.J. et al. Articles Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease : a pooled analysis of individual patient data // 2018. p 939–948.

7. Hlatky M.A. et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease : a collaborative analysis of individual patient data from ten randomised trials // Lancet. 2009. Т. 373. № 9670. p 1190–1197.

8. Hueb W. et al. Utility and quality-adjusted life-years in coronary artery disease // Medicine (Baltimore). 2017. № November. p 1–7.

9. Kang S. et al. Stent Thrombosis With Drug-Eluting Stents and Bioresorbable Scaffolds // 2016. p 1–10.

10. Le J. et al. Health-related quality of life in coronary heart disease : a systematic review and meta-analysis mapped against the International Classification of Functioning , Disability and Health // Qual. Life Res. 2018. № 3. p 201-211.

11. Maciej Banach, Maria Corina Serban, Amirhossein Sahebkar, Hector M. García-García, Dimitri P. Mikhailidis, Seth Martin, Brie Daniel, Jacek Rysz, Peter Toth, Steven Jones, Rani Hasan, Svetlana Mosteoru, Mahmoud Al Rifai, Michael Pencina P.W.S. Conventional drug-eluting and metallic stents : a systematic review and meta- analysis// 57 JACC. 2016. Т. 67. № 13. 20-16. Available at: http://www.onlinejacc.org/content/accj/67/13_Supplement/57.full.pdf (accessed 11.11.2018).

12. Palmerini T. et al. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients. // Am. Heart J. 2017. Available at: https://www.sciencedirect.com/science/article-/pii/S000-2870317301461?via%3Dihub accessed 11.11.2018).

13. Shah R. et al. Meta-Analysis Comparing Coronary Artery Bypass Grafting to Drug-Eluting Stents and to Medical Therapy Alone for Left Main Coronary Artery Disease. // Am. J. Cardiol. 2017. Available at: https://www.sciencedirect.com/science/article/pii/S0002914917306318?via%3Dihub accessed 11.11.2018).

14. Stevanovi J. et al. Multivariate Meta-Analysis of Preference- Based Quality of Life Values in Coronary Heart Disease // 2016. Т. 64. p 1–20.

15. Wang L. et al. Long-term Outcomes of Drug-eluting versus Bare-metal stent for ST-elevation Myocardial Infarction // 2014. p 529–538.



1. Grinshtein Yu.I., Kusaev V.V., Gubich S.G. Kachestvo zhizni bol'nykh, perenesshikh ostryi infarkt miokarda s razlichnymi vidami revaskulyarizatsii [Quality of life of patients with acute myocardial infarction with different types of revascularization]. Kardiologiya [Cardiology]. 2012. T. 5. p 92–95. [in Russian]

: 933

Көкенова М.Б., Мысаев А.О., Сиязбекова З.С. Качество жизни больных с ишемической болезнью сердца до и после оперативного лечения (стентирование и шунтирование): литературный обзор // Наука и Здравоохранение. 2018. 6 (Т.20). С. 31-38.

Kokenova M.B., Myssayev A.O., Siyazbekova Z.S. Quality of life of patients with ischemic heart disease before and after surgical treatment (stenting and bypassing): literary review. Nauka i Zdravookhranenie [Science & Healthcare]. 2018, (Vol.20) 6, pp. 31-38.

Көкенова М.Б., Мысаев А.О., Сиязбекова З.С. Жүректің ишемиялық ауруы бар науқастардың операциялық емге дейінгі және одан кейінгі өмір сапасы (стенттеу және шунттау): әдебиеттік шолу // Ғылым және Денсаулық сақтау. 2018. 6 (Т.20). Б. 31-38.